The global implantable neurostimulators market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by factors such as increasing prevalence of neurological disorders and technological advancements in the field of implantable neurostimulators. Deep brain stimulators are used for treating Parkinson's disease, epilepsy, and pain. Spinal cord stimulators are used for treating chronic pain conditions such as back pain and diabetic peripheral neuropathy. Vagal nerve stimulator is used for treating epilepsy and other seizure disorders. Sacral nerve stimulator is used for treating fecal incontinence in patients with spinal cord injury or multiple sclerosis (MS). Gastric stimulator is used for treatment of gastroparesis which causes delayed emptying of stomach contents into the small intestine or large intestine due to impaired vagus nerve function or pyloric obstruction. -The global market for implantable neurostimulators is expected to grow at a CAGR of 7.2% from 2016 to 2020. -Increasing prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the growth of the implantable neurostimulator market. -Increasing prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the growth of the implantable neurostimulator market. -Growing geriatric population base in developed countries is also contributing towards the growth in this segment due to increasing incidence rates among elderly people with neurological disorders such as Alzheimer's disease and dementia which require long term care and treatment with implanted devices like an implantable neurostimulator or deep brain stimulator (DBS). -Innovations in technology that have led to improved safety features have increased adoption rates for these devices by patients suffering from various types of diseases that affect their nervous system including Parkinson’s Disease, epilepsy, spinal cord injury etc, thereby boosting demand for these products across geographies globally.
Industry Growth Insights published a new data on “Implantable Neurostimulators Market”. The research report is titled “Implantable Neurostimulators Market research by Types (Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators, Others), By Applications (Parkinson's disease, Epilepsy, Pain, Others), By Players/Companies Medtronic, Boston Scientific, Abbott, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Neurostimulators Market Research Report
By Type
Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators, Others
By Application
Parkinson's disease, Epilepsy, Pain, Others
By Companies
Medtronic, Boston Scientific, Abbott, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Neurostimulators Market Report Segments:
The global Implantable Neurostimulators market is segmented on the basis of:
Types
Deep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson's disease, Epilepsy, Pain, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Abbott
- Cyberonics
- NeuroPace
- Synapse Biomedical
- NeuroSigma
- ReShape Lifesciences
- ElectroCore Medical
- Inspire Medical
- NEUROS
- SPR
- IMTHERA
- NEVRO
Highlights of The Implantable Neurostimulators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagal Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Stimulators
- Others
- By Application:
- Parkinson's disease
- Epilepsy
- Pain
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Neurostimulators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An implantable neurostimulator is a medical device that stimulates the nervous system to treat conditions such as chronic pain, epilepsy, and depression.
Some of the key players operating in the implantable neurostimulators market are Medtronic, Boston Scientific, Abbott, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences, ElectroCore Medical, Inspire Medical, NEUROS, SPR, IMTHERA, NEVRO.
The implantable neurostimulators market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Neurostimulators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Neurostimulators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Neurostimulators Market - Supply Chain
4.5. Global Implantable Neurostimulators Market Forecast
4.5.1. Implantable Neurostimulators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Neurostimulators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Neurostimulators Market Absolute $ Opportunity
5. Global Implantable Neurostimulators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Neurostimulators Market Size and Volume Forecast by Type
5.3.1. Deep Brain Stimulators
5.3.2. Spinal Cord Stimulators
5.3.3. Vagal Nerve Stimulators
5.3.4. Sacral Nerve Stimulators
5.3.5. Gastric Stimulators
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Neurostimulators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Neurostimulators Market Size and Volume Forecast by Application
6.3.1. Parkinson's disease
6.3.2. Epilepsy
6.3.3. Pain
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Neurostimulators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Neurostimulators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Neurostimulators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Neurostimulators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Neurostimulators Demand Share Forecast, 2019-2026
9. North America Implantable Neurostimulators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Neurostimulators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Neurostimulators Market Size and Volume Forecast by Application
9.4.1. Parkinson's disease
9.4.2. Epilepsy
9.4.3. Pain
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Neurostimulators Market Size and Volume Forecast by Type
9.7.1. Deep Brain Stimulators
9.7.2. Spinal Cord Stimulators
9.7.3. Vagal Nerve Stimulators
9.7.4. Sacral Nerve Stimulators
9.7.5. Gastric Stimulators
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Neurostimulators Demand Share Forecast, 2019-2026
10. Latin America Implantable Neurostimulators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Neurostimulators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Neurostimulators Market Size and Volume Forecast by Application
10.4.1. Parkinson's disease
10.4.2. Epilepsy
10.4.3. Pain
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Neurostimulators Market Size and Volume Forecast by Type
10.7.1. Deep Brain Stimulators
10.7.2. Spinal Cord Stimulators
10.7.3. Vagal Nerve Stimulators
10.7.4. Sacral Nerve Stimulators
10.7.5. Gastric Stimulators
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Neurostimulators Demand Share Forecast, 2019-2026
11. Europe Implantable Neurostimulators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Neurostimulators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Neurostimulators Market Size and Volume Forecast by Application
11.4.1. Parkinson's disease
11.4.2. Epilepsy
11.4.3. Pain
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Neurostimulators Market Size and Volume Forecast by Type
11.7.1. Deep Brain Stimulators
11.7.2. Spinal Cord Stimulators
11.7.3. Vagal Nerve Stimulators
11.7.4. Sacral Nerve Stimulators
11.7.5. Gastric Stimulators
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Neurostimulators Demand Share, 2019-2026
12. Asia Pacific Implantable Neurostimulators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Neurostimulators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Neurostimulators Market Size and Volume Forecast by Application
12.4.1. Parkinson's disease
12.4.2. Epilepsy
12.4.3. Pain
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Neurostimulators Market Size and Volume Forecast by Type
12.7.1. Deep Brain Stimulators
12.7.2. Spinal Cord Stimulators
12.7.3. Vagal Nerve Stimulators
12.7.4. Sacral Nerve Stimulators
12.7.5. Gastric Stimulators
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Neurostimulators Demand Share, 2019-2026
13. Middle East & Africa Implantable Neurostimulators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Neurostimulators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Neurostimulators Market Size and Volume Forecast by Application
13.4.1. Parkinson's disease
13.4.2. Epilepsy
13.4.3. Pain
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Neurostimulators Market Size and Volume Forecast by Type
13.7.1. Deep Brain Stimulators
13.7.2. Spinal Cord Stimulators
13.7.3. Vagal Nerve Stimulators
13.7.4. Sacral Nerve Stimulators
13.7.5. Gastric Stimulators
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Neurostimulators Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Implantable Neurostimulators Market: Market Share Analysis
14.2. Implantable Neurostimulators Distributors and Customers
14.3. Implantable Neurostimulators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cyberonics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NeuroPace
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Synapse Biomedical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NeuroSigma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ReShape Lifesciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ElectroCore Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Inspire Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NEUROS
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. SPR
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. IMTHERA
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. NEVRO
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook